UPC (UPC) Stock Price & Analysis
UPC (UPC) fell 10.55% to USD 3.39 as of July 25, 2026 at 01:45 UTC, according to Nexqual real-time market data.
UPC last closed at USD 3.79; the session ranged USD 3.31–3.78 on volume of 38,704 shares. Market capitalization is $2.25M, with a 52-week range of USD 2–17.96 (NCM). Source: Nexqual, July 25, 2026 at 01:45 UTC.
Key Statistics (as of July 25, 2026 at 01:45 UTC)
| Price | USD 3.39 |
|---|---|
| Change | ▼ 10.55% (down) |
| Previous Close | USD 3.79 |
| Open | USD 3.65 |
| Day Range | USD 3.31 – 3.78 |
| 52-Week Range | USD 2 – 17.96 |
| Volume | 38,704 shares |
| Market Cap | $2.25M |
| Exchange | NCM |
Technical Analysis (UPC)
Nexqual's technical model rates UPC "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 01:45 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 42.6 (neutral) |
| vs SMA50 | Below (USD 3.91) |
| MACD | -0.08 (negative) |
Analyst Ratings (UPC)
Wall Street analysts rate UPC "None", per Nexqual as of July 25, 2026 at 01:45 UTC.
| Consensus Rating | None |
|---|
Earnings (UPC)
Source: Nexqual, July 25, 2026 at 01:45 UTC.
Financials & Fundamentals (UPC)
| Total Revenue | $17.86M |
|---|---|
| Revenue Growth (YoY) | -14.10% |
| Gross Margin | +35.28% |
| Operating Margin | -6.77% |
| Profit Margin | -20.56% |
| ROE | -7.23% |
| Debt / Equity | 16.49 |
| Current Ratio | 4.07 |
| Total Cash | $33.59M |
| Total Debt | $9.26M |
| Free Cash Flow | $-10.24M |
Source: Nexqual, July 25, 2026 at 01:45 UTC.
Financial Health Score (UPC)
Nexqual rates UPC's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 01:45 UTC.
| Growth | Critical — Revenue -14% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Strong — $34M cash vs $9M debt, net cash position |
| Cash Flow | Weak — FCF negative: -$10M, burning cash |
| Efficiency | Critical — ROE -7%, ROA -2.7% |
Ownership (UPC)
| Insider Ownership | +11.38% |
|---|---|
| Institutional Ownership | +4.45% |
| Shares Outstanding | 631,761 |
| Float | 487,254 |
| Short % of Float | +38.12% |
Source: Nexqual, July 25, 2026 at 01:45 UTC.
Leadership (UPC)
UPC is led by Gang Lai (age 57), CEO & Chairman, per Nexqual as of July 25, 2026 at 01:45 UTC.
| CEO & Chairman | Gang Lai (age 57) |
|---|---|
| CFO & Director | Lin Yang (age 49) |
| Chief Operating Officer | Baochang Liu (age 44) |
Major Backers & Investors (UPC)
Notable institutional backers of UPC include UBS Group AG, according to Nexqual as of July 25, 2026 at 01:45 UTC.
Active Investors
| Investor | Stake |
|---|---|
| UBS Group AG | 0.17% |
Source: Nexqual, July 25, 2026 at 01:45 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PRFX | PRF Technologies Ltd. | USD 1.14 | ▼ 5.42% |
| KTTA | Pasithea Therapeutics Corp. | USD 0.46 | ▼ 1.09% |
| EEIQ | EpicQuest Education Group Inter | USD 2.16 | ▼ 6.9% |
| VRAX | Virax Biolabs Group Limited | USD 3.19 | ▼ 12.36% |
| ENSC | Ensysce Biosciences, Inc. | USD 0.26 | ▼ 7.96% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 01:45 UTC. This page is informational and not investment advice.